1. Home
  2. TNXP vs FSBW Comparison

TNXP vs FSBW Comparison

Compare TNXP & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • FSBW
  • Stock Information
  • Founded
  • TNXP 2007
  • FSBW 1936
  • Country
  • TNXP United States
  • FSBW United States
  • Employees
  • TNXP N/A
  • FSBW N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • FSBW Banks
  • Sector
  • TNXP Health Care
  • FSBW Finance
  • Exchange
  • TNXP Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • TNXP 335.6M
  • FSBW 308.6M
  • IPO Year
  • TNXP N/A
  • FSBW 2012
  • Fundamental
  • Price
  • TNXP $22.41
  • FSBW $39.69
  • Analyst Decision
  • TNXP Buy
  • FSBW Hold
  • Analyst Count
  • TNXP 1
  • FSBW 1
  • Target Price
  • TNXP $70.00
  • FSBW $44.00
  • AVG Volume (30 Days)
  • TNXP 1.1M
  • FSBW 18.3K
  • Earning Date
  • TNXP 11-11-2025
  • FSBW 10-22-2025
  • Dividend Yield
  • TNXP N/A
  • FSBW 2.83%
  • EPS Growth
  • TNXP N/A
  • FSBW N/A
  • EPS
  • TNXP N/A
  • FSBW 4.15
  • Revenue
  • TNXP $9,831,000.00
  • FSBW $139,676,000.00
  • Revenue This Year
  • TNXP $14.79
  • FSBW $9.62
  • Revenue Next Year
  • TNXP $933.49
  • FSBW $5.35
  • P/E Ratio
  • TNXP N/A
  • FSBW $9.53
  • Revenue Growth
  • TNXP N/A
  • FSBW 0.61
  • 52 Week Low
  • TNXP $6.76
  • FSBW $34.61
  • 52 Week High
  • TNXP $130.00
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 30.44
  • FSBW 44.84
  • Support Level
  • TNXP $23.60
  • FSBW $39.11
  • Resistance Level
  • TNXP $29.19
  • FSBW $40.63
  • Average True Range (ATR)
  • TNXP 1.63
  • FSBW 0.89
  • MACD
  • TNXP 0.12
  • FSBW -0.18
  • Stochastic Oscillator
  • TNXP 5.31
  • FSBW 22.58

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: